Meseclazone
From Self-sufficiency
File:Meseclazone.png | |
Systematic (IUPAC) name | |
---|---|
7-chloro-2-methyl-3,3a-dihydro-2H,9H-[1,2]oxazolo[3,2-b][1,3]benzoxazin-9-one | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 29053-27-8 |
ATC code | none |
PubChem | CID 34445 |
ChemSpider | 31698 |
Chemical data | |
Formula | C11H10ClNO3 |
Molar mass | 239.66 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Meseclazone (W-2395), also known as 2-methylseclazone, is a non-steroidal anti-inflammatory drug (NSAID) developed in the 1970s.[1][2] It functions as a prodrug to the 5-chloro derivative of salicyclic acid.[2] It was never marketed on account of toxicity issues, namely pertaining to the liver.[2]
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
- ↑ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- ↑ 2.0 2.1 2.2 Rainsford, K. D. (2004). Aspirin and related drugs. Washington, DC: Taylor & Francis. ISBN 0-7484-0885-1.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Analgesics
- Non-steroidal anti-inflammatory drugs